Page 1

December 2 , 2021 Human Chemistry , Human Solutions TEIJIN Regenerative Medicine of the Teijin Group Teijin Limited Securities code : 3401 ENHANCING THE QUALITY OF LIFE Deputy Chief Officer ( Corporate Strategy ) General Manager , Regenerative Medicine New Business Department Takayuki Nakano , Ph.D. , MBA